Hong J - Search Results

1

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.

Shen YA, Hong J, Asaka R, Asaka S, Hsu FC, Suryo Rahmanto Y, Jung JG, Chen YW, Yen TT, Tomaszewski A, Zhang C, Attarwala N, DeMarzo AM, Davidson B, Chuang CM, Chen X, Gaillard S, Le A, Shih IM, Wang TL. Shen YA, et al. Among authors: hong j. Cancer Res. 2020 Oct 15;80(20):4514-4526. doi: 10.1158/0008-5472.CAN-19-3971. Epub 2020 Aug 28. Cancer Res. 2020. PMID: 32859605 Free PMC article.

2

Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy.

Shen YA, Jung J, Shimberg GD, Hsu FC, Rahmanto YS, Gaillard SL, Hong J, Bosch J, Shih IM, Chuang CM, Wang TL. Shen YA, et al. Among authors: hong j. iScience. 2021 Oct 15;24(11):103297. doi: 10.1016/j.isci.2021.103297. eCollection 2021 Nov 19. iScience. 2021. PMID: 34816098 Free PMC article.

3

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC).

Hong J, Shen YA, Hsu CY, Huang P, Tomaszewski A, Gabrielson E, Shih IM, Gaillard S, Wang TL. Hong J, et al. Genes Dis. 2022 Mar 21;9(6):1408-1411. doi: 10.1016/j.gendis.2022.02.009. eCollection 2022 Nov. Genes Dis. 2022. PMID: 36157486 Free PMC article. No abstract available.

4

Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer.

Asaka S, Verma N, Yen TT, Hicks JL, Nonogaki H, Shen YA, Hong J, Asaka R, DeMarzo AM, Wang TL, Shih IM, Gaillard S. Asaka S, et al. Among authors: hong j. Int J Gynecol Cancer. 2024 Nov 4;34(11):1737-1744. doi: 10.1136/ijgc-2024-005920. Int J Gynecol Cancer. 2024. PMID: 39414312

5

Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.

Zhou X, Zhou R, Li Q, Jie X, Hong J, Zong Y, Dong X, Zhang S, Li Z, Wu G. Zhou X, et al. Among authors: hong j. Anticancer Drugs. 2019 Mar;30(3):241-250. doi: 10.1097/CAD.0000000000000709. Anticancer Drugs. 2019. PMID: 30640793

6

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.

Wang J, Zhang R, Lin Z, Zhang S, Chen Y, Tang J, Hong J, Zhou X, Zong Y, Xu Y, Meng R, Xu S, Liu L, Zhang T, Yang K, Dong X, Wu G. Wang J, et al. Among authors: hong j. J Hematol Oncol. 2020 Jul 20;13(1):99. doi: 10.1186/s13045-020-00926-x. J Hematol Oncol. 2020. PMID: 32690037 Free PMC article.

7

Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells.

Li Q, Zong Y, Li K, Jie X, Hong J, Zhou X, Wu B, Li Z, Zhang S, Wu G, Meng R. Li Q, et al. Among authors: hong j. Biol Res. 2019 Apr 16;52(1):22. doi: 10.1186/s40659-019-0231-x. Biol Res. 2019. PMID: 30992075 Free PMC article.

8

The effect of ionizing radiation on the subcellular localization and kinase activity of protein kinase CK2 in human non-small cell lung cancer cells.

Li Q, Li K, Zhang S, Zhou Y, Hong J, Zhou X, Li Z, Wu B, Wu G, Meng R. Li Q, et al. Among authors: hong j. Int J Radiat Biol. 2019 Nov;95(11):1462-1471. doi: 10.1080/09553002.2019.1642531. Epub 2019 Jul 23. Int J Radiat Biol. 2019. PMID: 31290713

9

Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer.

Zhou X, Zhou R, Rao X, Hong J, Li Q, Jie X, Wang J, Xu Y, Zhu K, Li Z, Wu G. Zhou X, et al. Among authors: hong j. Cell Death Dis. 2022 Jul 21;13(7):636. doi: 10.1038/s41419-022-05079-y. Cell Death Dis. 2022. PMID: 35864117 Free PMC article.

10

Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification.

Jeon Y, Kim JY, Ahn JS, Im YH, Choi K, Jeong SY, Jung Y, Jang J, Choi DH, Hong J, Kim HJ, Cho SY, Park YH. Jeon Y, et al. Among authors: hong j. Cancer Treat Res Commun. 2024 Dec 12;42:100857. doi: 10.1016/j.ctarc.2024.100857. Online ahead of print. Cancer Treat Res Commun. 2024. PMID: 39719737 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,987 results

Search Page

Filters